0
El 10 de junio de 2025, Health Canada publicó el 'Documento de orientación: Requisitos de información y presentación de medicamentos biológicos biosimilares (2025 - Proyecto revisado), en inglés, “...
More >- INICIO
-
Genéricos
Novedades
- FDA approves generic teriparatide and levetiracetam
- US generics launch and approval for Dr Reddy’s and Lupin
- Five Chinese companies join UN’s MPP for Covid-19 medicines
- South Korean companies to make generic Bridion and COVID-19 drugs
Investigación
- Japan’s drug shortage crisis: challenges and policy solutions
- Saudi FDA drug approvals and GMP inspections: trend analysis
- Generic medications in the Lebanese community: understanding and public perception
- Community pharmacists’ understanding of generic and biosimilar drugs: Lebanon case study
General
- Crecimiento de medicamentos genéricos en Brasil y Venezuela
- EMA launches European shortages monitoring platform to tackle persistent medicine shortages
- Penetración de los medicamentos genéricos en México y Brasil
- FDA releases one-year progress report for the Generic Drug Cluster
-
Biosimilares
Novedades
- UK MHRA approves biosimilars Zefylti (filgrastim) and Ahzantive (aflibercept)
- FDA approves ustekinumab biosimilar Starjemza
- EMA recommend approval for aflibercept, ustekinumab, and pegfilgrastim biosimilars
- FDA approves Hadlima and Otulfi as interchangeable biosimilars
- MORE EDITORIAL SECTIONS
- Search
